GRAIL Integrates Galleri Test into Epic EHR for 450 Health Systems
GRAIL will integrate its Galleri multi-cancer early detection test into Epic’s EHR, enabling approximately 450 health systems to order tests and receive results within patient portals. Implementation began in Q1 2026 with early adopters, and GRAIL expects broad availability by end 2026 to streamline workflows and reduce administrative burdens.
1. Integration with Epic EHR
GRAIL will integrate its Galleri multi-cancer early detection test into Epic’s Aura platform, enabling approximately 450 health systems to order tests directly at the point of care and receive results within existing patient portals.
2. Implementation Timeline
Implementation planning began in Q1 2026 with initial integrations and early adopter programs; GRAIL expects broad availability across Epic-powered health systems by end of 2026.
3. Operational Advantages
Embedding Galleri within the native EHR reduces manual processes, lowers administrative burdens, and streamlines clinician ordering and patient follow-up workflows.
4. Market and Clinical Impact
The integration aims to support routine early cancer detection, enhance patient experience, and accelerate adoption of Galleri across large health systems, potentially boosting long-term revenue growth.